NCT05387512 2026-01-06
A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer
Affiliated Hospital of Nantong University
Completed
Clinical Trials
4 trialsNCT05547737 2022-09-21
NSCLC
Henan Cancer Hospital
Unknown
NCT04793139 2021-03-11
Efficacy and Safety of Camrelizumab in Real-World Prospective Study
Guangdong Association of Clinical Trials
Unknown
NCT04631146 2020-11-17
Efficacy and Safety of Camrelizumab in Real-World Study
Guangdong Association of Clinical Trials
Unknown